Noom vs Wisp
Neither Noom nor Wisp has an FDA warning letter on record. No price lines up like for like: Noom and Wisp publish prices for different products.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Noom / Wisp
Noom
5.8/10
Wisp
7.1/10
Neither Noom nor Wisp pays us. Links to them earn nothing. Scores: Noom 5.8, Wisp 7.1. How we are paid
What the record shows
- 01
Neither Noom nor Wisp has an FDA warning letter on record.
- 02
Neither names the pharmacy that compounds its medication.
- 03
No price lines up like for like: Noom and Wisp publish prices for different products.
- 04
Only Noom lists a price for compounded semaglutide injection and brand-name tirzepatide pen. Only Wisp lists a price for compounded oral semaglutide.
- 05
Wisp lists 39 states. Noom publishes no state list.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Noom
Wisp
$179/mo
$2,148 a year
$349/mo
$4,188 a year
$225/mo
$2,700 a year
Read off each seller’s own pages. Noom: October 30, 2026. Wisp: September 28, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Noom
5.8/10- Sells compounded semaglutide injection and brand-name tirzepatide pen, which Wisp does not price
- Names no compounding pharmacy
- Publishes no state list
The case for Wisp
7.1/10- Sells compounded oral semaglutide, which Noom does not price
- Names no compounding pharmacy
Scores
Noom 5.8 · Wisp 7.1 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Noom vs Wisp: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- TrimRx6.4
From $299/mo
Visit site - Direct Meds7.1
From $249/mo
Visit site - SnagRx9.2
From $99/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks